MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Free Cash flow
-$5,667,166
Unit: Dollar
Positive Cash Flow Breakdown
    • Unrealized gain from changes in ...
    • Proceeds from notes payable, net...
    • Accretion on convertible notes
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Realized gain and trading gains ...
    • Repayment of notes payable
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
-
-
1,632,581
-
General and administrative
-
-
10,279,981
-
Total operating expenses
-
-
11,912,562
-
Loss from operations
-
-
-11,912,562
-
Unrealized gain on digital assets
-
-
1,812,348
-
Realized gain on sale of digital assets
-
-
4,197,394
-
Trading gains, net
-
-
97
-
Foreign currency transaction loss
-
-
-521
-
Change in fv of warrant liability
-
-
0
-
Change in fv of derivative
-
-
-55,146
-
Interest income
-
-
107,595
-
Interest expense
-
-
283,011
-
Total other income (expense), net
-
-
5,911,425
-
Net loss
-20,173,130
-35,059,852
-1,155,292
-1,781,255
Stock based compensation - option grants
105,210
114,166
0
0
Stock based compensation - stock options and warrants
-
-
1,331,079
42,674
Change in fair value of warrant liability
-
-
0
-12,859
Advisory shares committed for issuance
0
8,113,318
-
-
Depreciation & amortization expense
-
20,044
3,985
1,489
Depreciation and amortization expense
40,324
-
-
-
Accrued interest expense - related parties
-
-
-
6,301
Change in fair value of derivative liability
215,993
48,279
55,146
-
Interest expense
-
8,387
243,177
1
Non-cash interest
1,212,398
-
-
-
Accretion on convertible notes
1,859,744
851,018
-
-
Unrealized gain from changes in fair value of digital assets
-13,196,057
-22,061,472
6,009,838
-
Realized gain and trading gains on digital assets
2,004,495
-
-
-
Digital assets received as yield income
282,732
-
-
-
Non-cash digital asset operating expenses
-
8,726
2,429,487
-
Proceeds from sales of digital assets, net of purchases
177,901
-
-
-
Prepaid expenses and other current assets
-296,013
273,390
193,457
431,011
Accounts payable and accrued expenses
168,453
2,134,541
-384,643
448,494
Operating lease liability
-9,758
2,122
-
-
Net cash used in operating activities
-5,667,166
-2,067,727
-3,818,202
-1,726,166
Cash from short term investments
-
-
2,000,000
-
Restricted cash
-
-
8,000,000
-
Redemption of short term investments
-1,500,000
-500,000
-
-
Purchases of property, plant and equipment
0
9,394
21,424
22,540
Cash paid to acquire operating lease
-
-
18,363
-
Cash acquired in accordance with merger
-
-
-15,345
-
Net cash provided by (used in) investing activities
1,500,000
490,606
-10,024,442
-22,540
Cash proceeds from issuance of common stock in ipo
-
-
-323,319
0
Proceeds from notes payable, net of original issue discount
5,970,000
-
100
0
Proceeds from notes payable
-
995,000
10,000,000
-
Payment of debt issuance costs
510,000
75,000
946,000
-
Cash advances from related parties
-
-
11,900
0
Repayment of notes payable
1,000,000
-
-
-
Cash advances paid to related parties
-
-
250,000
0
Proceeds from subscription receivable on subsidiary shares
1,002
-
-
-
Net cash provided by financing activities
3,466,002
920,000
8,492,681
0
Net change in cash and cash equivalents
-701,163
-657,121
-5,349,962
-1,748,706
Cash, cash equivalents, and restricted cash, beginning of period
6,986,617
6,986,617
6,986,617
3,455
Cash, cash equivalents and restricted cash, end of period
8,278,371
-
-
-
Cash paid for interest
160,000
-
-
-
Debt issuance costs accrued in connection with notes payable
865,000
-
-
-
Restricted cash
-
8,000,000
8,000,000
-
Cash and cash equivalents
278,371
-
-
-
Total cash, cash equivalents, and restricted cash
8,278,371
8,979,534
-
6,986,617
Total cash, cash equivalents, and restricted cash
-
8,979,534
-
-
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from notespayable, net of original...$5,970,000 (2288.00%↑ Y/Y)Redemption of short terminvestments-$1,500,000 Proceeds fromsubscription receivable on...$1,002 Net cash provided byfinancing activities$3,466,002 (-71.42%↓ Y/Y)Net cash provided by(used in) investing...$1,500,000 (11319.99%↑ Y/Y)Canceled cashflow$2,505,000 Net change in cashand cash...-$701,163 (-108.03%↓ Y/Y)Canceled cashflow$4,966,002 Unrealized gain fromchanges in fair value of...-$13,196,057 Accretion on convertiblenotes$1,859,744 Non-cash interest$1,212,398 Prepaid expenses andother current assets-$296,013 (-116.55%↓ Y/Y)Proceeds from sales ofdigital assets, net of...$177,901 Accounts payable andaccrued expenses$168,453 (135.69%↑ Y/Y)Stock basedcompensation - option grants$105,210 (-93.81%↓ Y/Y)Depreciation andamortization expense$40,324 Repayment of notes payable$1,000,000 something is missing-$995,000 Payment of debt issuancecosts$510,000 Net cash used inoperating activities-$5,667,166 (-67.60%↓ Y/Y)Canceled cashflow$17,056,100 Net loss-$20,173,130 (-558.27%↓ Y/Y)Realized gain and tradinggains on digital...$2,004,495 Digital assets receivedas yield income$282,732 Change in fair value ofderivative liability$215,993 Operating lease liability-$9,758

Apimeds Pharmaceuticals US, Inc. (APUS)

Apimeds Pharmaceuticals US, Inc. (APUS)